Evolution Infographics
Cell & Gene Therapy: Increasing Demand for Viral Vectors Drives Biomanufacturing Innovation & CDMO Investment
Cell & Gene Therapy: Increasing Demand for Viral Vectors Drives Biomanufacturing Innovation & CDMO Investment
Evolution Infographics
2018 Global Drug Development IPO Analysis: $10.24B Raised in Strongest Year on Record
2018 Global Drug Development IPO Analysis: $10.24B Raised in Strongest Year on Record
Evolution Infographics
RNAi Therapeutics Come of Age: Exploring the Peaks & Troughs of Alnylam’s Thirty Year Journey to First Approval
RNAi Therapeutics Come of Age: Exploring the Peaks & Troughs of Alnylam’s Thirty Year Journey to First Approval
Evolution Infographics
Global Drug Development IPOs: 26 Companies Raise $3.18B in Q3 as First Pre-Revenue Biotechs List on HKEX
Global Drug Development IPOs: 26 Companies Raise $3.18B in Q3 as First Pre-Revenue Biotechs List on HKEX
News & Analysis
Democratising DNA: 23andMe & GSK Collaboration Highlights Data Quality & Privacy Concerns; Can Blockchain Offer a Disruptive Solution?
Democratising DNA: 23andMe & GSK Collaboration Highlights Data Quality & Privacy Concerns; Can Blockchain Offer a Disruptive Solution?
Evolution Infographics
Global Drug Development IPOs: NASDAQ Dominance Continues as 26 Companies Raise Over $2.54B in Q2
Global Drug Development IPOs: NASDAQ Dominance Continues as 26 Companies Raise Over $2.54B in Q2
Evolution Infographics
Lonza Opens World’s Largest Cell & Gene Therapy Manufacturing Plant in Texas
Lonza Opens World’s Largest Cell & Gene Therapy Manufacturing Plant in Texas
Evolution Infographics
All Eyes on Oxford Nanopore after further £100m funding raised at £1.5B Valuation
All Eyes on Oxford Nanopore after further £100m funding raised at £1.5B Valuation
Evolution Infographics
Charles River Laboratories M&A Activity Analysis: A Differentiated Strategy Delivering Results
Charles River Laboratories M&A Activity Analysis: A Differentiated Strategy Delivering Results
News & Analysis
Making Large-Scale Biomanufacturing More Efficient and Affordable: Have Novo Nordisk Foundation Made a Major Breakthrough?
Making Large-Scale Biomanufacturing More Efficient and Affordable: Have Novo Nordisk Foundation Made a Major Breakthrough?
Evolution Infographics
Global Therapeutic IPO Review: $6.4B Raised as Bullish Investors Back Biologics & Gene Therapies Despite Slowed Growth in 2017
Global Therapeutic IPO Review: $6.4B Raised as Bullish Investors Back Biologics & Gene Therapies Despite Slowed Growth in 2017
Evolution Infographics
Gene Therapy Manufacturing: An Impending Crisis or Temporary Growing Pains?
Gene Therapy Manufacturing: An Impending Crisis or Temporary Growing Pains?